GTx Phase IIIb Study Will Evaluate Therapy For Prostate Cancer Treatment Side Effects
This article was originally published in The Pink Sheet Daily
Executive Summary
GTx is initiating an extension of its Phase III clinical trial of Acapodene in prostate cancer patients.